Solutions
Orion® Molecular Design
Web-Access Platform
Cloud-Native Architecture
Small Molecule Discovery Suite
Commercially Available Compounds
Lead Discovery
Large Scale Virtual Screening
Shape Searching (ROCS)
Shape Searching GPU (FastROCS)
Docking (OEDocking)
Binding Site Comparison (SiteHopper)
Lead Optimization
Shape Searching (ROCS)
Free Energy Calculation (NES)
Electrostatic Similarity (EON)
Fragment Replacement (BROOD)
Ligand Pose Prediction (POSIT)
Ligand Modification (GAMEPLAN)
Ligand Entropy (FREEFORM)
Quantun Calculations (Psi4-based)
pKa Prospector
Biomodeling
Protein Preparation (SPRUCE)
Binding Site Comparison (SiteHopper)
Crystallography (AFITT)
Molecular Data Preparation
Property Calculator (FILTER)
Conformer Generation (OMEGA)
Tautomer and Charge (QUACPAC)
Toolkit Development Platform
Cheminformatics
Molecular Similarity (GraphSim TK)
Chemical Representation (OEChem TK)
Modeling
OpenEye Consulting
Drug Discovery Services
Crystal Structure Prediction
Method Development and Coding
Partnerships
Available Databases
Commercially Available Compound Databases
Prepared Protein Structure Database (MMDS)
Iridium Database
pKa Database
Conformational Databases
Visualizer and Data Analysis
Web-based Visualizer and Analysis (Orion)
Desktop Visualizer (VIDA)
Business
Licensing Philosophy
Pricing
Academic Licensing
Request Evaluation
Science
Publications
Presentations
Webinars
Blogs
CUP Events
SAMPL
Support
Documentation
Downloads
Platforms
Report A Bug
About
News
Events
Philosophy
Board of Directors
Staff
Careers
Contact Us
Privacy Policy
Subscribe
Careers
Click To Search
News
View Items In A Gallery View
Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration
OpenEye Scientific Partners with Enamine to Accelerate Early Drug Discovery
OpenEye Scientific Announces Appointment of Dr. Giovanna Scapin to Board of Directors
OpenEye Scientific Achieves AWS High Performance Computing Competency
OpenEye Scientific Incorporates Mcule Compound Library in Orion™ Platform
Sygnature Discovery Adopts OpenEye Scientific’s Orion™ Platform to Strengthen Molecular Design Services
Applications and Toolkits Release 2020.2
Easily organize and share data in Orion™
Gigadock™ Functionality in Orion™ Molecular Design Platform Rapidly Identifies Novel Chemical Entities for GPCR Targets
Orion v2020.2 Update
Molecular Design Platform Accelerating Research For Huntington’s Disease
OpenEye Applications v2020.0 and OpenEye Toolkits v2020.0 Released
Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific
Redesign Science and OpenEye Scientific announce strategic partnership
Anthony Nicholls to speak at BAGIM on AI - Feb 12, 2020
OpenEye Applications v2019.November Released
OpenEye Toolkits v2019.Oct Released
2nd RSC-BMCS/RSC-CICAG Artificial Intelligence in Chemistry | Cambridge, UK
OpenEye Congratulates Outstanding Junior Faculty Award Winners at the Fall 2019 ACS | San Diego
D3R 2019 Workshop | San Diego, CA
OpenEye Applications v2019.May Released
Eighth Joint Sheffield Conference on Chemoinformatics
OpenEye Toolkits v2019.Apr Released
MACC-NYAGIM Symposium 2019
BioIT World Expo 2019
Outstanding Junior Faculty ACS Spring 2019 Award Winners | Orlando
Drug Discovery Chemistry 2019
OpenEye Applications v2018.Nov Released
Cyrus Biotechnology integrates tools from OpenEye
OpenEye Toolkits v2018.Oct Released
22nd EuroQSAR | Greece
OMEGA v3.0.1 Released
256th ACS National Meeting | Boston
OpenEye Toolkits v2018.Feb released
OMEGA v3.0.0 released
VIDA v4.4.0 released
11th ICCS - Noordwijkerhout, The Netherlands
BioIT World Expo 2018
255th ACS National Meeting | New Orleans
Drug Discovery Chemistry 2018
OpenEye Toolkits v2017.Oct released
AWS re:Invent 2017
PSDI 2017 Cambridge, UK
13th German Conference on Cheminformatics 2017
Vienna Summer School of Drug Design 2017
OpenEye Announces Pfizer to Adopt Orion Cloud Platform for Computational Chemistry
255th ACS Outstanding Junior Faculty Award Winners | New Orleans
OpenEye Congratulates Outstanding Junior Faculty Award Winners at the 254th ACS | Washington, DC
ROCS v3.2.2 released
254th ACS National Meeting
OpenEye Toolkits v2017.Jun released
Drug Discovery Summit 2017
BioIT World Expo 2017
AFITT v2.4.1 released
OpenEye Toolkits v2017.Feb Released
Drug Discovery Chemistry
253rd ACS National Meeting
Drug Discovery, London UK
Penny J. Gilmer Grant for Women Graduate Students and Post-docs
2016-11 | AWS re:Invent | Las Vegas, NV
2016-11 | PSDI | Malmö, SE
2016-10 | OpenEye Toolkits v2016.Oct Released
2016-10 | QUACPAC v1.7.0 Released
2016-08 | 252nd ACS National Meeting | Philadelphia, PA
2016-07 | 7th Joint Sheffield Conference on Cheminformatics | Sheffield, UK
2016-06 | SZYBKI v1.9.0 Released
2016-06 | OpenEye Toolkits v2016.Jun released
2016-04 | Bio-IT World | Boston, MA
2016-03 | UK-QSAR 2016 | Stevenage, UK
2016-03 | 251st ACS National Meeting | San Diego, CA
2016-02 | Advances and Progress in Drug Design | London, UK
2016-02 | OpenEye Toolkits v2016.Feb Released
2015-12 | Pacifichem | Honolulu, HI
2015-11 | 4th Autumn School of Cheminformatics | Tokyo, JP
2015-11 | PSDI | Munich, DE
2015-10 | OpenEye Toolkits v2015.Oct released
2015-09 | Vienna Summer School | Vienna, AT
2015-09 | SBDD 2015 | Lausanne, CH
2015-09 | ROCS v3.2.1 released
2015-08 | 250th ACS National Meeting | Boston, MA
2015-08 | Computational Chemical Biology Conference | Cairns, AU
2015-08 | Outstanding Junior Faculty Award Winners ACS | Boston, MA
2015-08 | Drug Discovery Re-invented Conference | Ascot, UK
2015-08 | BROOD v3.0 released
2015-07 | Gordon Research Conference | Mount Snow, VT
2015-07 | SZMAP v1.2.1 released
2015-06 | OpenEye Toolkits v2015.June released
2015-06 | Property Based Drug Design | Boston, MA
2015-04 | Bio-IT World | Boston, MA
2015-04 | Drug Discovery Chemistry | San Diego, CA
2015-03 | OpenEye Congratulates Outstanding Junior Faculty Award Winners ACS | Denver, CO
2015-03 | 249th ACS National Meeting | Denver, CO
2015-02 | OpenEye ROCS featured in "The Scientist"
2015-02 | OpenEye Toolkits v2015.Feb released
2015-05 | Molecular Medicine Tri-Conference | San Francisco, CA
2010-06 | JCUP I | Tokyo, JP
